On-Demand Webcast

Share

Program Content

Activities

  • ICI in GEJ Cancers
    Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2020

    Expires: December 16, 2021

Faculty

cover img faculity

Yelena Y. Janjigian, MD

Associate Attending Physician
Chief, 
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

cover img faculity

Zev A. Wainberg, MD

Professor of Medicine and Surgery
Co-Director, GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Merck Sharp & Dohme Corp.